My Sudler & Hennessey advertising colleagues placed bets on whether I was the only representative from a medical education agency attending Cannes Lions Health … But who says medical education can’t ...

Chief creative officers (CCO) have come quite a ways from the Mad Men era. Gone are the days of hard drinking in the office, overnight work days and a my-way-or-the-highway approach to copy. Modern ...

The harder your brain works at your job, the less likely you may be to have memory and thinking problems later in life, according to a new study published in the journal Neurology. This study does not ...

PHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular ...

PHOENIX, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company pioneering ...

Company reaches next clinical trial milestone for the intramuscular treatment of Chronic Lower Back Pain with the first novel allogenic cellular therapy in the United States PHOENIX, Oct. 10, 2023 ...

The Burn Pit Initiative is expected to serve as a foundational program within a broader biodefense framework that may be extended to additional exposure-related and environmental health threats. About ...

Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026 PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Creative Medical ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine solutions for multiple indications, including pain management, ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Creative Medical Technology Holdings, Inc. (CELZ) one of those ...

Global assignment of this unique name enhances international clarity, strengthens regulatory positioning, and supports olastrocel’s advancement across large unmet-need global markets PHOENIX, Dec. 02, ...